Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
Resource MedicinalProductDefinition "mp367b9089c0743a2330f4c6e82b40ee41"
Profile: MedicinalProductDefinition (ePI)
identifier: id: EU/1/16/1157/002
type: Medicinal Product (Medicinal Product Type#MedicinalProduct)
domain: Human use (Medicinal Product Domain#Human)
status: active (PublicationStatus#active)
indication: Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.
legalStatusOfSupply: Medicinal product subject to medical prescription (rmswi#100000072084)
classification: insulin glargine and lixisenatide (WHO ATC#A10AE54)
name
productName: Suliqua 100 units/ml + 50 micrograms/ml solution for injection in a pre-filled pen
type: Full name (220000000000#220000000001)
part
part: Suliqua
type: Invented name part (220000000000#220000000002)
part
part: Insulin glargine, Lixisenatide
type: Scientific name part (220000000000#220000000003)
part
part: 100 units/ml + 50 ug/ml
type: Strength part (220000000000#220000000004)
part
part: Solution for injection
type: Pharmaceutical dose form part (220000000000#220000000005)
Usages
Country Jurisdiction Language Denmark (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#DK) Denmark (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#DK) English (Tags for the Identification of Languages#en)